Cost cutting, new drugs boost Amgen shares
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”27-04-2014″ enddate=”27-10-2014″ width=”300″ height=”245″] Cost cutting moves and new drugs are starting to pay off for Amgen Inc., as the biotech giant raised earnings guidance after a stronger-than-expected third quarter. The company said Oct. 27 that strong demand for its white blood cell booster, Neulasta, and increased sales of newer Read More →
Read More →T.O. Boulevard revamp hinges on key project
Champions of the Thousand Oaks Boulevard Specific Plan are feverishly optimistic in their expectations for the future of the three-mile-long, mostly commercial corridor. But some remaining constraints are putting all eyes on the fate of one particular project — developer Rick Principe’s 53-unit mixed-use concept at 1850 Thousand Oaks Blvd.
Read More →Teledyne to raise $125M in debt sale
Thousand Oaks-based industrial conglomerate Teledyne Technologies hopes to raise up to $125 million in operating capital by selling debt. The company said that on Dec. 4 it will issue $30 million of senior unsecured notes at 2.6 percent due Dec. 4, 2019 and $95 million of 3.1 percent senior unsecured notes due on Dec. 6, Read More →
Read More →Editorial: Happy birthday, Camarillo and Thousand Oaks
We’d be remiss if we did not take the opportunity to make note of the 50th anniversaries of two important communities in our region. Camarillo and Thousand Oaks both mark their golden anniversaries in 2014 and, all fanfare aside, it is noteworthy that both have made significant economic impacts on our region. Thousand Oaks presents Read More →
Read More →